ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.58
0.55%
US Tech 100
20,860.00
1.42%
S&P 500
6,067.70
0.92%
US Dollar vs CAD
1.43972
-0.03%
Bitcoin
101,754.54
0.42%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Chimerix Inc (CMRX)

  7. Chimerix Inc (CMRX) News

CMRX

Chimerix (CMRX)

Chimerix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CMRX
DateTimeSourceHeadlineSymbolCompany
01/24/20253:01PMGlobeNewswire Inc.Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
01/13/20256:00AMGlobeNewswire Inc.Chimerix to Speak Today at The White House Cancer Moonshot ForumNASDAQ:CMRXChimerix Inc
01/10/20252:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
01/10/20252:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
01/10/20251:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
01/10/20251:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
01/10/20251:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
01/10/20251:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
12/30/20246:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
12/30/20246:00AMGlobeNewswire Inc.Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse GliomaNASDAQ:CMRXChimerix Inc
12/10/20248:55AMAllPennyStocks.comSmall Cap Soars On FDA Submission PlansNASDAQ:CMRXChimerix Inc
12/10/20247:49AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
12/09/20243:01PMGlobeNewswire Inc.Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-EndNASDAQ:CMRXChimerix Inc
12/06/20243:01PMGlobeNewswire Inc.Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
11/14/20243:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
11/11/20246:00AMGlobeNewswire Inc.Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO MeetingNASDAQ:CMRXChimerix Inc
11/07/20246:28AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMRXChimerix Inc
11/07/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
11/07/20246:00AMGlobeNewswire Inc.Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
11/01/20246:00AMGlobeNewswire Inc.Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024NASDAQ:CMRXChimerix Inc
10/30/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
10/18/20243:31PMGlobeNewswire Inc.Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
09/03/20246:00AMGlobeNewswire Inc.Chimerix to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:CMRXChimerix Inc
08/30/20243:05PMGlobeNewswire Inc.Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
08/13/20243:05PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CMRXChimerix Inc
08/13/20246:22AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMRXChimerix Inc
08/13/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
08/13/20246:00AMGlobeNewswire Inc.Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
08/09/202412:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CMRXChimerix Inc
08/09/202411:01AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
 Showing the most relevant articles for your search:NASDAQ:CMRX

Your Recent History

NASDAQ
TNXP
Tonix Pharmaceuticals
NASDAQ
MULN
Mullen Automotive
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
MVNT
Movement Industries (PK)
USOTC
LQMT
Liquidmetal Technologies (QB)
USOTC
SPZI
Spooz (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
NBRI
North Bay Resources (PK)
USOTC
AZRH
Azure (PK)
USOTC
GTCH
GBT Technologies (PK)
USOTC
GRLF
Green Leaf Innovations (PK)
USOTC
UMAV
UAV Corpoation (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
RNVA
Rennova Health (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads